Modulation of Interleukin-10 Production by Therapeutic Drugs
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
2
Page:
95-106
Author(s):
Bernard Royer, Jean-Pierre Kantelip and Michel Arock
Infections and Urinary Stone Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
975-981
Author(s):
Nadeem U. Rahman, Maxwell V. Meng and Marshall L. Stoller
Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
307-321
Author(s):
Koji Sawada, Tetsuichiro Muto, Takashi Shimoyama, Masamichi Satomi, Toshio Sawada, Hirokazu Nagawa, Nobuo Hiwatashi, Hitoshi Asakura and Toshifumi Hibi
Novel Intervention Strategies for Helicobacter pylori Treatment
Journal:
Current Drug Targets - Infectious Disorders
Volume:
2
Page:
331-338
Author(s):
Brian Noonan and Richard A. Alm
Aspartic Proteinases in Disease: A Structural Perspective
Journal:
Current Drug Targets
Volume:
3
Page:
155-173
Author(s):
J. B. Cooper
Subject Index To Volume 7
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
85-97
Author(s):
Science Publishers Bentham
Helicobacter Pylori Infection, Immune Response and Vaccination
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
199-208
Author(s):
A. Lembo, L. Caradonna, T. Magrone, M. L. Mastronardi, D. Caccavo, E. Jirillo and L.Amati
Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
241-253
Author(s):
G. Ranieri and G. Gasparini
New Issues about Nitric Oxide and its Effects on the Gastrointestinal Tract
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
881-908
Author(s):
M. J. Martin, M. D. jimenez and V. Motilva
Helicobacter pylori Current Chemotherapy and New Targets for Drug Design
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
355-392
Author(s):
John S. Williamson